Santhera Pharmaceuticals Holding AG
OTC: SPHDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Dario Eklund
- Employees
- 78
- Headquarters
- Pratteln, Switzerland
- IPO year
- 2014
- Market cap
- $344.8M
- Website
- https://www.santhera.com
Loading SPHDF…
Loading profile data…Frequently asked questions about SPHDF
What does Santhera Pharmaceuticals Holding AG (SPHDF) do?
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments o...
Where does SPHDF trade?
Santhera Pharmaceuticals Holding AG (SPHDF) trades on the Other OTC.
What sector is SPHDF in?
Santhera Pharmaceuticals Holding AG (SPHDF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Santhera Pharmaceuticals Holding AG?
Dario Eklund is the chief executive officer of Santhera Pharmaceuticals Holding AG (SPHDF).
Where is Santhera Pharmaceuticals Holding AG headquartered?
Santhera Pharmaceuticals Holding AG is headquartered in Switzerland.
Does SPHDF pay a dividend?
Santhera Pharmaceuticals Holding AG (SPHDF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPHDF go public?
Santhera Pharmaceuticals Holding AG (SPHDF) completed its initial public offering in 2014.